Company Filing History:
Years Active: 2019-2022
Title: **Haizhou Fang: Innovating in Biotechnology**
Introduction
Haizhou Fang is a prominent inventor based in Guangdong, China, recognized for his significant contributions to the field of biotechnology. With three patents to his name, Fang has focused on developing innovative solutions in human health, particularly in the production and application of recombinant human-basic fibroblast growth factor (rh-bFGF).
Latest Patents
Fang's latest patents include important advancements in the formulation and production of rh-bFGF. His first patent details a mutated nucleic acid molecule of recombinant human-basic fibroblast growth factor and its pharmaceutical composition, highlighting the utility and application of rh-bFGF in medical treatments. The second patent outlines a method for producing soluble rh-bFGF, which provides an efficient approach to obtain this valuable protein for therapeutic applications.
Career Highlights
Fang currently works at Zhuhai Essex Bio-pharmaceutical Co., Ltd., where he leverages his expertise to drive innovation in bio-pharmaceutical development. His work not only enhances existing methodologies but also paves the way for new therapeutic interventions.
Collaborations
Throughout his career, Fang has collaborated with talented colleagues such as Xinzhi Wang and Peimin Dai. These collaborations have fostered a productive research environment, allowing for the exchange of ideas and accelerating advancements in their field.
Conclusion
In summary, Haizhou Fang stands out as a dedicated inventor in the biotechnology sector. His patents on recombinant human-basic fibroblast growth factor demonstrate his commitment to developing impactful medical solutions. With an impressive career trajectory and collaborative efforts, Fang continues to contribute to important innovations in healthcare.